Hospital-acquired venous thromboembolism (HA-VTE) is one of the leading preventable causes of in-hospital mortality, but prevention of VTE in hospitalized medical patients remains challenging, as preventive measures such as pharmacological thromboprophylaxis (TPX) need to be tailored to individual thrombotic risk. The broad objective of this project is to improve VTE prevention strategies in hospitalized medical patients by prospectively examining VTE risk factors (including mobility) and comparing existing risk assessment models.
Study Type
OBSERVATIONAL
Enrollment
1,353
Inselspital, Bern University Hospital
Bern, Switzerland
Geneva University Hospital
Geneva, Switzerland
University Hospital of Lausanne
Lausanne, Switzerland
Venous thromboembolism
Symptomatic, objectively confirmed fatal and non-fatal hospital-acquired venous thromboembolism, including symptomatic distal and proximal deep vein thrombosis and pulmonary embolism after hospital admission
Time frame: Within 90 days of initial hospital admission
Venous thromboembolism
Symptomatic, objectively confirmed fatal and non-fatal hospital-acquired venous thromboembolism, including symptomatic distal and proximal deep vein thrombosis and pulmonary embolism during hospitalization
Time frame: During the initial hospitalization, an average of 7 days
All-cause mortality
All-cause mortality (all causes of death will be considered)
Time frame: During hospitalization (an average of 7 days) and up to 90 days of initial hospital admission
Major bleeding
Major bleeding will be defined as fatal bleeding, symptomatic bleeding at critical sites (intracranial, intraspinal, intraocular, retroperitoneal, intraarticular, pericardial, or intramuscular with compartment syndrome), or bleeding with a reduction of hemoglobin of at least 20 g/L or bleeding leading to transfusion of 2 or more units of packed red blood cells according to the definition of the International Society on Thrombosis and Haemostasis
Time frame: During hospitalization (an average of 7 days) and up to 90 days of initial hospital admission
Clinically relevant non-major bleeding
Clinically relevant non-major bleeding, defined as overt bleeding that does not meet criteria for major bleeding but is associated with a medical intervention, unscheduled physician contact (visit or telephone call), or pain or impairment of activities of daily life
Time frame: During hospitalization (an average of 7 days) and up to 90 days of initial hospital admission
Patient autonomy in the activities of daily living
Patient autonomy in the activities of daily living as assessed by the modified Barthel Index
Time frame: At discharge (an average of 7 days after initial hospital admission) and at 90 days after admission
Length of hospital stay
Length of hospital stay, defined as the time/date of discharge minus time/date of admission at the hospital ward
Time frame: within 90 days of initial hospital admission
Subsequent hospitalizations
Subsequent hospitalization, defined as hospital readmissions
Time frame: Within 90 days of initial hospital admission
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.